MAPT and Alzheimer disease: Because of biological characteristics and clinical feasibility, AD biomarkers are classified into three binary categories7: A (amyloid‐β deposition), T (tau accumulation: p‐tau), and N (neurodegeneration or neural injury), each characterized typically dichotomously as either negative (−) or positive (+) and called the ATN framework.